Antigny Fabrice, Norez Caroline, Becq Frédéric, Vandebrouck Clarisse
Institut de Physiologie et de Biologie Cellulaires, Université de Poitiers, CNRS UMR 6187, Poitiers Cedex, France.
Cell Calcium. 2008 Feb;43(2):175-83. doi: 10.1016/j.ceca.2007.05.002. Epub 2007 Jun 27.
Retention of F508del-CFTR proteins in the endoplasmic reticulum (ER) is dependent upon chaperone proteins, many of which require Ca(2+) for optimal activity. Here, we show in human tracheal gland CF-KM4 cells, that after correction of F508del-CFTR trafficking by miglustat (N-butyldeoxynojirimycin) or low temperature (27 degrees C), the Ca(2+) mobilization is decreased compared to uncorrected cells and becomes identical to the Ca(2+) response observed in non-CF MM39 cells. In CF-KM4 and human nasal epithelial CF15 cells, we also show that inhibiting vesicular trafficking by nocodazole prevents not only the rescue of F508del-CFTR but also the Ca(2+) mobilization decrease. Finally, experiments using the CFTR inhibitor CFTR(inh)-172 showed that the presence but not the channel activity of F508del-CFTR at the plasma membrane is required to decrease the Ca(2+) mobilization in corrected CF cells. These findings show that correction of the abnormal trafficking of F508del-CFTR proteins might have profound consequences on cellular homeostasis such as the control of intracellular Ca(2+) level.
F508del-CFTR蛋白在内质网(ER)中的滞留依赖于伴侣蛋白,其中许多伴侣蛋白需要Ca(2+)才能达到最佳活性。在此,我们在人气管腺CF-KM4细胞中发现,在通过米格列醇(N-丁基脱氧野尻霉素)或低温(27摄氏度)纠正F508del-CFTR转运后,与未纠正的细胞相比,Ca(2+)动员减少,并且变得与在非囊性纤维化(CF)的MM39细胞中观察到的Ca(2+)反应相同。在CF-KM4和人鼻上皮CF15细胞中,我们还表明,用诺考达唑抑制囊泡运输不仅会阻止F508del-CFTR的挽救,还会阻止Ca(2+)动员的减少。最后,使用CFTR抑制剂CFTR(inh)-172的实验表明,质膜上F508del-CFTR的存在而非通道活性是降低纠正后的CF细胞中Ca(2+)动员所必需的。这些发现表明,纠正F508del-CFTR蛋白的异常转运可能会对细胞内稳态产生深远影响,例如对细胞内Ca(2+)水平的控制。